5649-9 |
Fluoride |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Fluoride [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
5649-9 |
|
|
|
|
Both |
|
|
|
0 |
Fluoride SerPl-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Fl; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
56490-6 |
Hemoglobin.gastrointestinal.lower^2nd specimen |
PrThr |
Stool |
Pt |
Ord |
IA |
|
ACTIVE |
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
56490-6 |
|
IA |
|
|
Observation |
|
|
|
0 |
Hemoccult sp2 Stl Ql IA |
|
|
|
N |
|
Bowel movement; Chemistry; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FIT; FOB; FOBT; Gastrocult; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; IAA; iFOBT; Low; MEIA; Occult blood; Occult blood in stool; Ordinal; Point in time; Post immunization; PR; QL; Qual; Qualitative; Random; Screen; Second; sp2; Spec; Stl; Stool = Fecal; SUDS |
2.73 |
2.29 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Changed Component to Hemoglobin.gastrointestinal.lower to make the term more descriptive and easier to find. The method was changed to IA for consistency across Classes. |
0 |
56491-4 |
Hemoglobin.gastrointestinal.lower^3rd specimen |
PrThr |
Stool |
Pt |
Ord |
IA |
|
ACTIVE |
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --3rd specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
56491-4 |
|
IA |
|
|
Observation |
|
|
|
0 |
Hemoccult sp3 Stl Ql IA |
|
|
|
N |
|
Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FIT; FOB; FOBT; Gastrocult; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; IAA; iFOBT; Low; MEIA; Occult blood; Occult blood in stool; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; sp3; Spec; Stl; Stool = Fecal; SUDS |
2.73 |
2.29 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Changed Component to Hemoglobin.gastrointestinal.lower to make the term more descriptive and easier to find. The method was changed to IA for consistency across Classes. |
0 |
56492-2 |
Insulin^6M post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Insulin [Units/volume] in Serum or Plasma --6 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;uIU/mL |
|
|
|
|
|
|
CHAL |
|
56492-2 |
|
|
|
|
Observation |
|
|
|
0 |
Insulin 6M p chal SerPl-aCnc |
|
|
|
N |
|
6M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente |
2.7 |
2.29 |
|
|
|
|
|
|
|
u[IU]/mL |
|
|
|
0 |
56493-0 |
Lutropin^10M post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;uIU/mL |
|
|
|
|
|
|
CHAL |
|
56493-0 |
|
|
|
|
Observation |
|
|
|
0 |
LH 10M p chal SerPl-aCnc |
|
|
|
N |
|
10M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.29 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
56494-8 |
Lutropin^2H post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;uIU/mL |
|
|
|
|
|
|
CHAL |
|
56494-8 |
|
|
|
|
Observation |
|
|
|
0 |
LH 2h p chal SerPl-aCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.29 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
56495-5 |
Lutropin^3H post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;uIU/mL |
|
|
|
|
|
|
CHAL |
|
56495-5 |
|
|
|
|
Observation |
|
|
|
0 |
LH 3h p chal SerPl-aCnc |
|
|
|
N |
|
3h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.29 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
56496-3 |
Prolactin^2H post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
56496-3 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin 2h p chal SerPl-aCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; p chal; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.29 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
56497-1 |
Choriogonadotropin.beta subunit |
ARat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Choriogonadotropin.beta subunit [Units] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
IU/24 H |
|
|
|
|
|
|
CHEM |
|
56497-1 |
|
|
|
|
Both |
|
|
|
0 |
B-HCG 24h Ur |
|
|
|
N |
|
1 day; 24 hours; 24HR; Arbitrary rate; B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; QNT; Quan; Quant; Quantitative; Tumor marker; UA; UR; Urn |
2.7 |
2.29 |
|
|
|
|
|
|
|
/(24.h) |
|
|
|
0 |
56498-9 |
Androstenedione^30M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHAL |
|
56498-9 |
|
|
|
|
Observation |
|
|
|
0 |
Androst 30M p chal SerPl-mCnc |
|
|
|
N |
|
30M p chal; After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.29 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
56499-7 |
Somatotropin^45M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56499-7 |
|
|
|
|
Both |
|
|
|
0 |
GH 45M p chal SerPl-mCnc |
|
|
|
N |
|
45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.73 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. |
0 |
565-2 |
Colony count |
Num |
XXX |
Pt |
Ord |
VC |
|
ACTIVE |
Colony count [#] in Specimen Qualitative by Visual count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
565-2 |
|
VC |
|
|
Both |
|
|
|
0 |
CC Spec Ql VC |
|
|
|
|
|
CC; Cnt; Colonies; Count; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Number; Ordinal; Other; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Visual count |
2.69 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
5650-7 |
Fluoride |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Fluoride [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
5650-7 |
|
|
|
|
Both |
|
|
|
0 |
Fluoride Ur-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Fl; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
56500-2 |
Somatotropin^3H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56500-2 |
|
|
|
|
Both |
|
|
|
0 |
GH 3h p chal SerPl-mCnc |
|
|
|
N |
|
3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.73 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. |
0 |
56501-0 |
Somatotropin^6H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56501-0 |
|
|
|
|
Observation |
|
|
|
0 |
GH 6h p chal SerPl-mCnc |
|
|
|
N |
|
6h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56502-8 |
Somatotropin^7H post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --7 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
56502-8 |
|
|
|
|
Observation |
|
|
|
0 |
GH 7h p chal SerPl-aCnc |
|
|
|
N |
|
7h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
56503-6 |
Somatotropin^8H post XXX challenge |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Units/volume] in Serum or Plasma --8 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
56503-6 |
|
|
|
|
Observation |
|
|
|
0 |
GH 8h p chal SerPl-aCnc |
|
|
|
N |
|
8h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
56504-4 |
Corticotropin^15M post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Corticotropin [Mass/volume] in Plasma --15 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ng/L |
|
|
|
|
|
|
CHAL |
|
56504-4 |
|
|
|
|
Observation |
|
|
|
0 |
ACTH 15M p chal Plas-mCnc |
|
|
|
N |
|
15M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker |
2.7 |
2.29 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
56505-1 |
Corticotropin^45M post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Corticotropin [Mass/volume] in Plasma --45 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ng/L |
|
|
|
|
|
|
CHAL |
|
56505-1 |
|
|
|
|
Observation |
|
|
|
0 |
ACTH 45M p chal Plas-mCnc |
|
|
|
N |
|
45M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker |
2.7 |
2.29 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
56506-9 |
Corticotropin^2H post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Corticotropin [Mass/volume] in Plasma --2 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ng/L |
|
|
|
|
|
|
CHAL |
|
56506-9 |
|
|
|
|
Observation |
|
|
|
0 |
ACTH 2h p chal Plas-mCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker |
2.4 |
2.29 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
56507-7 |
Dehydroepiandrosterone sulfate^30M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mcg/dL; mcg/mL |
|
|
|
|
|
|
CHAL |
|
56507-7 |
|
|
|
|
Observation |
|
|
|
0 |
DHEA-S 30M p chal SerPl-mCnc |
|
|
|
N |
|
30M p chal; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf |
2.7 |
2.29 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
56508-5 |
Dehydroepiandrosterone sulfate^1H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mcg/dL; mcg/mL |
|
|
|
|
|
|
CHAL |
|
56508-5 |
|
|
|
|
Observation |
|
|
|
0 |
DHEA-S 1h p chal SerPl-mCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf |
2.7 |
2.29 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
5651-5 |
Fluoride |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Fluoride [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/24 H |
|
|
|
|
|
|
DRUG/TOX |
|
5651-5 |
|
|
|
|
Both |
|
|
|
0 |
Fluoride 24h Ur-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Fl; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
mg/(24.h) |
|
|
|
0 |
56510-1 |
Dehydroepiandrosterone^1H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
56510-1 |
|
|
|
|
Observation |
|
|
|
0 |
DHEA 1h p chal SerPl-mCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56511-9 |
Calcitonin^2M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
56511-9 |
|
|
|
|
Observation |
|
|
|
0 |
Calcit 2M p chal SerPl-mCnc |
|
|
|
N |
|
2M p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker |
2.7 |
2.29 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |